|
NRIFF
|
There should be an announcement soon about P 2% Phase 3 Trial in Acute Pain...
|
|
NRIFF
|
Well, I would expect by mid-February as it was supposed to since it was their...
|
|
NRIFF
|
The nature of the news was within my expectations. The timing of the...
|
|
NRIFF
|
There is no one seller. Watch out for those stop lose setting.
|
|
NRIFF
|
Fully agree with you and also see option 3 as the outcome. Expect a quick...
|
|
NRIFF
|
The late insiders activities simply relates to the company principles having...
|
|
NRIFF
|
Never the less, the question remains and is quite valide. If the...
|
|
NRIFF
|
Well, now that you put it this way, with the $60 M of cash no dept. and the...
|
|
NRIFF
|
I too pondered on the undervalued share price and more specifically the...
|
|
NRIFF
|
WF10 FDA results. That’s in at least 3 years from now if all goes well. ...
|
|
NRIFF
|
The plan might be all what you said and more. However, if one'...
|
|
NRIFF
|
indee, the nuvo curst has strick again. It never fail. You should...
|
|
NRIFF
|
Before you get too excited with new uses of WF10, first NRI must hold the...
|
|
NRIFF
|
Yes, someone known's what every body should known. That is WF10 potential...
|
|
NRIFF
|
There it starts. Just as predicted, the need for dilution in order to...
|
|
NRIFF
|
at $10/bottle.. I see from you math skill how shrew an investor you are...
|
|
NRIFF
|
You cannot compaire P2% with vlotragen in the hope of estimating a sale...
|
|
T.FCO
|
Warrants?? what the duce are you talking about. Has any of you genius...
|
|
NRIFF
|
I can't tell you why the stock price is what it is now. Though, as...
|
|
NRIFF
|
overflowing, you confuse me. I only see that you have not considered...
|